Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kura Oncology (KURA) Tax Provisions (2025 - 2026)

Kura Oncology has reported Tax Provisions over the past 2 years, most recently at $8000.0 for Q1 2026.

  • Quarterly Tax Provisions fell 96.46% to $8000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $79000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $297000.0 for FY2025, 85.28% down from the prior year.
  • Tax Provisions was $8000.0 for Q1 2026 at Kura Oncology, down from $71000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $226000.0 in Q1 2025 and troughed at $8000.0 in Q1 2026.